-
False-Positive One-Hour Glucose Screens are Associated with Higher Rates of Perinatal Complications than Negative Screens; Dont be Mislead by the Short Take; More Information Regarding Single vs Double Layer Closure of the Uterus During Cesarean Section
-
Survival rates were similar in patients with advanced-stage ovarian cancer who underwent IDS or PDS. The rates of surgical resection and morbidity were reduced after IDS. IDS can be safely used in unresectable advanced-stage ovarian cancer.
-
Sinus and Allergy Health Partnership Releases New Guidelines for Treatment of Bacterial Rhinosinusitis; Steroids Not Linked to Risk of Fractures; ADT Puts Men at Risk for Osteoporosis; Study Shows Valsartan May Improve Sexual Function in Postmenopausal Women; New Direct-to-Consumer Pharma Advertising Rules Considered
-
-
-
Results from the estrogen-progestin arm of the Womens Health Initiative confirm (after central adjudication of the diagnoses) an increase in venous thrombosis associated with a standard dose of postmenopausal hormone therapy.
-
Nearly 70% of patients achieving a CR after primary therapy eventually recurred. Most recurrences occurred more than 6 months from completion of primary chemotherapy, and the use of second line agents at the time of recurrence was effective.
-
Two premenopausal patients with resis tant endometriosis were successfully treated with a combination of the aromatase inhibitor anastrozole, Prometrium, calcitrol, and rofecoxib. Both patients had been diagnosed with endometriosis via laparoscopy, and had undergone GnRH suppression.
-
Smith and colleagues performed a case-control study of venous thrombosis and hormone users in postmenopausal women registered in a large health maintenance organization (the Group Health Cooperative) in the state of Washington.
-
The Infection Risk of Acid-Suppressing Drugs; Is Rosuvastatin As Safe As Other Statins?; Which Estrogen Preparation is the Safest?; FDA Actions.
